Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply

Andrea Cipriani; Nicoletta Adamo; Cinzia Del Giovane; David Coghill; Tobias Banaschewski; Chris Hollis; Alessandro Zuddas; Emily Simonoff; Samuele Cortese

doi:10.1016/S2215-0366(18)30396-1

Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply

Andrea Cipriani (Lead / Corresponding author), Nicoletta Adamo, Cinzia Del Giovane, David Coghill, Tobias Banaschewski, Chris Hollis, Alessandro Zuddas, Emily Simonoff, Samuele Cortese

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	871-873
Number of pages	3
Journal	Lancet Psychiatry
Volume	5
Issue number	11
Early online date	26 Oct 2018
DOIs	https://doi.org/10.1016/S2215-0366(18)30396-1
Publication status	Published - Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2215-0366(18)30396-1

Cite this

@article{cd58bbf696bb4901b91cf8270869e561,

title = "Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply",

author = "Andrea Cipriani and Nicoletta Adamo and Giovane, {Cinzia Del} and David Coghill and Tobias Banaschewski and Chris Hollis and Alessandro Zuddas and Emily Simonoff and Samuele Cortese",

year = "2018",

month = nov,

doi = "10.1016/S2215-0366(18)30396-1",

language = "English",

volume = "5",

pages = "871--873",

journal = "Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply

AU - Cipriani, Andrea

AU - Adamo, Nicoletta

AU - Giovane, Cinzia Del

AU - Coghill, David

AU - Banaschewski, Tobias

AU - Hollis, Chris

AU - Zuddas, Alessandro

AU - Simonoff, Emily

AU - Cortese, Samuele

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85055573969&partnerID=8YFLogxK

U2 - 10.1016/S2215-0366(18)30396-1

DO - 10.1016/S2215-0366(18)30396-1

M3 - Letter

VL - 5

SP - 871

EP - 873

JO - Lancet Psychiatry

JF - Lancet Psychiatry

SN - 2215-0366

IS - 11

ER -

Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply

UN SDGs

Access to Document

Other files and links

Cite this